Vimarsana
Biggest News Aggregation in the World

Page 24 - Stroke Statistics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stroke Statistics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stroke Statistics Today - Breaking & Trending Today

egnite, Inc. Expands into Cardiovascular Disease Supported by New Data on the State of Care for Patients with Atrial Fibrillation - Vimarsana News

egnite, Inc. Expands into Cardiovascular Disease Supported by New Data on the State of Care for Patients with Atrial Fibrillation

Company to focus on improving the quality of care for all cardiovascular patients in the U.S.

New Analysis Reveals Icosapent - GuruFocus.com - Vimarsana News

New Analysis Reveals Icosapent - GuruFocus.com

GuruFocus Article or News written by GuruFocusNews and the topic is about:

Royal Philips: Philips at ESOC 2022: showcasing integrated solutions across the stroke care pathway - Vimarsana News

Royal Philips: Philips at ESOC 2022: showcasing integrated solutions across the stroke care pathway

May 3, 2022 Suite of solutions across the stroke care pathway are aimed at improving diagnostic confidence and time to treatment, helping reduce the risk of a second strokeNew results on health economic

Aspirin 101: What You Need To Know About This Foundational Therapy - Vimarsana News

Aspirin 101: What You Need To Know About This Foundational Therapy

(BPT) - There is no more familiar item in your medicine cabinet than a bottle of aspirin. In fact, aspirin has been sold for over a century as an over-the-counter

People With Heart Defects May Be at a Greater Risk for Severe COVID-19 Illness - Vimarsana News

People With Heart Defects May Be at a Greater Risk for Severe COVID-19 Illness

Among those at the highest risk for the most severe COVID-19 illness were patients who had a heart defect and another health condition, were ages 50 and older, or were men, according to the study.